Vanguard Global Advisers »

Serina Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Serina Therapeutics (SER) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Serina Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Serina Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Serina Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $713 368 1.94

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Serina Therapeutics

Vanguard Group
Vanguard Capital Management
Warren Averett Asset Management
Geode Capital Management
BlackRock
Broadwood Capital
Jane Street
Vanguard Fiduciary Trust
Streettalk Advisors
Keel Point
Northern Trust
State Street Corporation
Caitong International Asset Management
Wells Fargo & Company
Tower Research Capital

View all funds holding Serina Therapeutics